Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 901–1,000 of 1,001
Advanced heart failure: non-pharmacological approach
Correale, M., Monaco, I., Tricarico, L., Bottigliero, D., Sicuranza, M., Forno, B. D., Godeas, G., Teri, A. L., Maiorano, A., Perulli, R., et al. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09786-1 · Cited by 11
Immunosuppressive therapy to reduce mitral regurgitation in Libman–Sacks endocarditis: a case report
Ishizu, K., Isotani, A., Yamaji, K., & Andò, K. (2019) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytz133 · Cited by 11
The optimal treatment strategy for secondary mitral regurgitation: a subject of ongoing debate
Petrus, A. H. J., Klautz, R. J. M., Bonis, M. D., Langer, F., Schäfers, H., Wakasa, S., Vahanian, A. S., Obadia, J., Assi, R., Acker, M. G., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz238 · Cited by 11
MitraClip in Asia ― Current Adoption and Regional Data ―
Wong, N., & Yeo, K. K. (2019) · Circulation Reports · doi:10.1253/circrep.cr-19-0074 · Cited by 11
Unidades de insuficiência cardíaca: estado da arte na abordagem da insuficiência cardíaca
Timóteo, A. T., Pereira‐da‐Silva, T., Moreira, R. I., Gonçalves, A., Soares, R. M., & Ferreira, F. (2020) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2020.02.007 · Cited by 11
Clinical impact of intervention strategies after failed transcatheter mitral valve repair
Alessandrini, H., Dreher, A., Harr, C., Wohlmuth, P., Meincke, F., Hakmi, S., Ubben, T., Kück, K., Hassan, K., Willems, S., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-20-01008 · Cited by 11
Edge-to-edge repair: past challenge, current case selection and future advances
Sorajja, P., & Ukaigwe, A. C. (2021) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2020-mv-17 · Cited by 11
Lopes, P. M., Albuquerque, F., Freitas, P., Gama, F. F., Horta, E., Reis, C., Abecasis, J., Trabulo, M., Ferreira, A. M., Aguíar, C., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab023 · Cited by 11
Buck, T., Eiswirth, N., Farah, A., Kahlert, H. A., Patsalis, P., Kahlert, P., & Plicht, B. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.02.017 · Cited by 11
“8% [51 of 222]).(6,28) In our assessment of the results to understand MR recurrence after TMVR, we found (1) that significantly increasedMV tethering at baseline in patients with FMR with MR recurrence, who also had significantly larger values of tenting index, tenting(vol), LVEDVi, and VCA, was associated with poor 6…”
BackgroundIschemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies
Vinciguerra, M., Grigioni, F., Romiti, S., Benfari, G., Rose, D., Spadaccio, C., Cimino, S., Bellis, A. D., & Greco, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050447 · Cited by 11
Tokarek, T., Dziewierz, A., & Dudek, D. (2021) · Advances in Interventional Cardiology · doi:10.5114/aic.2021.107493 · Cited by 11
Vignati, C., Martino, F. D., Muratori, M., Salvioni, E., Tamborini, G., Bartorelli, A. L., Pepi, M., Alamanni, F., Farina, S., Cattadori, G., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13518 · Cited by 11
Pausch, J., Girdauskas, E., Conradi, L., & Reichenspurner, H. C. (2021) · JTCVS Techniques · doi:10.1016/j.xjtc.2021.09.019 · Cited by 11
“TRANSCATHETER EDGE-TO-EDGE REPAIR FOR SMR Contradictory data regarding the prognostic effect of transcatheter edge-to-edge repair (TEER) in patients with heart failure has been published.(36,37) Whereas the results of the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure…”
ResultMiura, M., Okuda, S., Murata, K., Nagai, H., Ueyama, T., Nakao, F., Shimokawa, M., Yamamoto, T., & Ikeda, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.764528 · Cited by 11
“In this regard, recent advances in transcatheter edge-to-edge repair (TEER) technology (3) have been drawing attention to treating FMR associated with left ventricular dysfunction and remodeling.”
BackgroundRole of 3D Transesophageal Echocardiography for Transcatheter Mitral Valve Repair—A Mini Review
Hirasawa, K., & Izumo, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.815304 · Cited by 11
“However, the ideal puncture site was slightly different between theMRmorphologies (23, 24).”
BackgroundPercutaneous Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation
Wong, N., & Yeo, K. K. (2022) · International Journal of Heart Failure · doi:10.36628/ijhf.2021.0041 · Cited by 11
Brunner, S., Wolfrum, M., Moccetti, F., Stämpfli, S. F., Attinger‐Toller, A., Bossard, M., Matt, P., Cuculi, F., Kobza, R., & Toggweiler, S. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30114 · Cited by 11
3D Intracardiac Echocardiography in Mitral Transcatheter Edge-to-Edge Repair
Blusztein, D. I., Lehenbauer, K. R., Sitticharoenchai, P., Cahill, T. J., Mihatov, N., Ng, V., Hamid, N. B., George, I., Kodali, S., & Hahn, R. T. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2022.05.022 · Cited by 11
Differences in patterns of progression of secondary mitral regurgitation
Layoun, H., Mentias, A. G., Kanaan, C. N., Badwan, O. Z., Matta, M., Kassab, J. T., Gillinov, M. A., Hodges, K., Griffin, B. P., Kapadia, S. R., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac200 · Cited by 11
Self-citationA Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
Kwok, C. S., Satchithananda, D. K., Ahmed, F. Z., Chue, C. D., Barker, D., Patwala, A., Duckett, S. G., & Mallen, C. D. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120455 · Cited by 11
Demir, O. M., Conradi, L., Prendergast, B., Ho, E. C., Montorfano, M., Duncan, A., Denti, P., Modine, T., Rodés‐Cabau, J., Taramasso, M., et al. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.01.017 · Cited by 11
Self-citationOutcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients With Rheumatic Heart Disease
Elzeneini, M., Ashraf, H. M., Mahmoud, A., Elgendy, I. Y., Elbadawi, A., Assaf, Y., Anderson, R. D., & Jneid, H. M. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.01.034 · Cited by 11
Du, Y., Han, H., Zhang, T., Shen, H., Han, W., Jia, S., Yu, Y., Guo, Y., Wang, Z., Liu, Y., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102095 · Cited by 11
Echocardiography in Transcatheter Structural Heart Disease Interventions
Patel, H. R., Raisinghani, A., & DeMaria, A. N. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.11.009 · Cited by 11
The Year in Cardiology 2018: Valvular Heart Disease
Wojakowski, W., & Baumgartner, H. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy893 · Cited by 9
Medvedovsky, A. T., Tonchev, I., Tahiroglu, I., Lotan, C., Gilon, D., Planer, D., Danenberg, H. D., Beeri, R., & Shuvy, M. (2019) · Structural Heart · doi:10.1080/24748706.2019.1618514 · Cited by 11
“Recently, the results of the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial, which compared the MitraClip implantation plus medical therapy to medical therapy alone in patients with HF and severe functional MR, show…”
ResultJogu, H. R., Arora, S., Strassle, P. D., Patel, C., Patil, N. S., Venkatesh, S., Alkhaimy, H., Ramm, C. J., Qamar, A., Kim, S. M., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28479 · Cited by 11
“However, most recently, COAPT study from the United States and Canada has proven the safety and efficacy of TMVR in functional MR and reported its association with a lower incidence of hospitalizations for heart failure and all-cause mortality within 2 years follow-up.(29) In summary, the results from multiple studies…”
Arruda, J. A., Lemke, V. D. M. G., Júnior, J. M., Barbosa, A. H. P., de Quadros, A. S., Pedra, C. A. C., Cardoso, C. D. O., Guérios, Ê. E., Ribeiro, H. B., Gubolino, L. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190841 · Cited by 11
Cork, D. P., McCullough, P. A., Mehta, H. S., Barker, C. M., Gunnarsson, C., Ryan, M. P., Baker, E. R., Houten, J. V., Mollenkopf, S. A., & Verta, P. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12653 · Cited by 11
Barth, S., Hautmann, M. B., Arvaniti, E., Kikec, J., Kerber, S., Zacher, M., Halbfaß, P., Ranosch, P., Lehmkuhl, L., Foldyna, B., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01733-7 · Cited by 11
Lipiecki, J., Fahrat, H., Monzy, S., Caillot, N., Siminiak, T., Johnson, T. J., Vogt, S., Stark, M. A., & Goldberg, S. L. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12955 · Cited by 11
Antithrombotische Therapie nach strukturellen kardialen Interventionen
Hochholzer, W., Nührenberg, T. G., Flierl, U., Olivier, C. B., Landmesser, U., Möllmann, H., Dörr, M., Mehilli, J., Schäfer, A., Duerschmied, D., et al. (2020) · Der Kardiologe · doi:10.1007/s12181-020-00441-w · Cited by 11
Stolz, L., Orban, M., Braun, D., Stark, K., Steffen, J., Orban, M., Hagl, C. M., Maßberg, S., Näbauer, M., & Hausleiter, J. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.035 · Cited by 11
Mohananey, D., Aljadah, M. M., Smith, A. A. H., Haines, J. F., Patel, S., Villablanca, P., & Ramakrishna, H. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.04.013 · Cited by 11
Roles of Cardiac Computed Tomography in Guiding Transcatheter Tricuspid Valve Interventions
Layoun, H., Schoenhagen, P., Wang, T. K. M., Puri, R., Kapadia, S. R., & Harb, S. C. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01547-7 · Cited by 11
Self-citationThe Need for Transcatheter Mitral Valve Replacement
Sorajja, P., Cavalcante, J. L., & Gössl, M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.062 · Cited by 11
Volume-Outcome Relationships for Transcatheter Mitral Valve Repair
Stone, G. W. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.05.008 · Cited by 11
Self-citationThe Complex Phenotypic Expressions of Functional Mitral Regurgitation
Grayburn, P. A., & Packer, M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.10.010 · Cited by 11
Self-citationRecurrent Mitral Regurgitation After MitraClip: Defining Success and Predicting Outcomes
Hassan, A., & Eleid, M. F. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.122.011837 · Cited by 11
Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices
Furman, D., & Whisenant, B. K. (2024) · Structural Heart · doi:10.1016/j.shj.2024.100335 · Cited by 10
Self-citationConflicts of interest in clinical practice: lessons learned from cardiovascular medicine.
Ronco, D., Albuquerque, A. M., Cuartas, M. M., Anselmi, A., Sádaba, R., Barili, F., Sousa‐Uva, M., Brophy, J. M., Quintana, E., Musumeci, F., et al. (2024) · PubMed Central · doi:10.1093/ejcts/ezae296 · Cited by 10
Interventional Therapies for Chronic Heart Failure: An Overview of Recent Developments
Guo, B., Shi, S., Guo, Y., Xiong, J., Wang, B., Dong, Z., Gao, D., & Tu, Y. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15114 · Cited by 10
Left Atrial to Left Ventricular Volume Ratio in Patients With Severe Functional Mitral Regurgitation
Koschatko, S., Heitzinger, G., Pávó, N., Spinka, G., Prausmüller, S., Mascherbauer, K., Dannenberg, V., Torrefranca, C., Koschutnik, M., Donà, C., et al. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.017872 · Cited by 10
Heart failure evidence update 2026
Liori, S., Kapelios, C. J., Savarese, G., & Filippatos, G. S. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10609-3 · Cited by 10
“The COAPT trial had established TEER efficacy for secondary mitral regurgitation (MR) in HFrEF [69].”
Guazzi, M., Generati, G., Borlaug, B. A., Alfonzetti, E., Sugimoto, T., Castelvecchio, S., Menicanti, L., & Bandera, F. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00125.2020 · Cited by 10
Nazir, S., Ahuja, K. R., Virk, H. U. H., Changal, K., Soni, R., Shekhar, S., Kaur, M., Bazarbashi, N., Ramanathan, P. K., & Gupta, R. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.06.050 · Cited by 10
Waechter, C., Ausbuettel, F., Chatzis, G., Fischer, D., NEF, H. M., Barth, S., Halbfaß, P., Deneke, T., Kerber, S., Divchev, D., et al. (2020) · Journal of Interventional Cardiology · doi:10.1155/2020/6542028 · Cited by 10
Short term outcomes after transcatheter mitral valve repair
Tripathi, B., Sawant, A. C., Sharma, P., Tandon, V., Patel, T., Klein, J., & Pershad, A. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.11.050 · Cited by 10
Anaesthesia for minimally invasive cardiac procedures in the catheterization lab
Reid, C. S., Meineri, M., Riva, T., Pilgrim, T., Räber, L., & Luedi, M. M. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001007 · Cited by 10
“Although the Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation (MITRA-FR) trial showed comparable rates of death and heart failure hospitalizations at 1 year in patients with TMVr or medical treatment [41], TMVr resulted in lower rates of deat…”
BackgroundResultPrognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair
Tanaka, T., Kavsur, R., Spieker, M., Iliadis, C., Metze, C., Horn, P., Sugiura, A., Baldus, S. E., Kelm, M., Nickenig, G., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01908-w · Cited by 10
Löw, K., Orban, M., Stocker, T. J., Mehr, M., Deseive, S., Gmeiner, J., Hagl, C. M., Maßberg, S., Näbauer, M., Hausleiter, J., et al. (2021) · Structural Heart · doi:10.1080/24748706.2021.1954272 · Cited by 10
Takaya, Y., Akagi, T., Hara, H., Kanazawa, H., Ikari, Y., Isotani, A., Shirai, S., Kubo, S., Morikawa, T., Naganuma, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-22-0048 · Cited by 10
Namazi, F., Delgado, V., Pio, S. M., Marsan, N. A., Asch, F. M., Medvedofsky, D. A., Weissman, N. J., Zhou, Z., Redfors, B., Lindenfeld, J. M., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab224 · Cited by 10
Self-citationSubannular repair in secondary mitral regurgitation with restricted leaflet motion during systole
Pausch, J., Harmel, E. K., Reichenspurner, H. C., Kempfert, J., Kuntze, T., Owais, T., Holubec, T., Walther, T., Krane, M., Vitanova, K., et al. (2023) · Heart · doi:10.1136/heartjnl-2022-322239 · Cited by 10
Maj, D., Jasińska‐Gniadzik, K., Kopiec, T., Wieteska, M., Gąsecka, A., Rdzanek, A., Kraaijeveld, A. O., Pujdak, K., Grabowski, M., & Pietrasik, A. (2023) · Cardiology Journal · doi:10.5603/cj.a2023.0029 · Cited by 10
“COAPT was a multicenter, randomized, controlled, parallel-group trial which enrolled 614 patients [23].”
BackgroundMethodInfluentialDevadoss, R., Dhillon, G. S., Sharma, P., Verma, R. K., Munjal, R. S., & Kashyap, R. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11010015 · Cited by 10
The scientific targets: the myocardium, the vasculature and the body’s response to heart failure
Vidal-Pérez, R., & Jankowska, E. A. (2024) · Global Cardiology · doi:10.4081/cardio.2024.19 · Cited by 10
Giordano, A., Ferraro, P., Finizio, F., Corcione, N., Cimmino, M., Biondi‐Zoccai, G., Denti, P., Rubbio, A. P., Petronio, A. S., Bartorelli, A. L., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033605 · Cited by 10
“7–10 While these premises hold robustly in patients with de novo mitral regurgitation, individuals with prior SMVR or TEER represent a uniquely challenging setting.”
BackgroundRomanò, M. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2023.0681 · Cited by 10
“From and mortality, 17,18 whereas transcatheter repair of TR improved only the QoL.”
Outcomes and Complications of Mitral and Tricuspid Transcatheter Edge-to-edge Repair
Arnautovic, J. Z., Ya’qoub, L., Wajid, Z., Jacob, C., Murlidhar, M., Damlakhy, A., & Walji, M. (2024) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2024.08 · Cited by 10
Growing Evidence for Edge-to-Edge Repair in Secondary Mitral Regurgitation
Stolz, L., Stocker, T. J., Lurz, P. C., & Hausleiter, J. (2025) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2025.01.429 · Cited by 10
Filomena, D., Cimino, S., Maestrini, V., Cantisani, D., Petronilli, V., Mancone, M., Tonti, G., Pedrizzetti, G., & Agati, L. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.05.022 · Cited by 10
Anesthetic Considerations for Transcatheter Tricuspid Valve Repair
Zoller, J. K., & Gregory, S. H. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.09.040 · Cited by 10
Bonow, R. O., O’Gara, P. T., Adams, D. H., Badhwar, V., Bavaria, J. E., Elmariah, S., Hung, J., Lindenfeld, J., Morris, A. A., Satpathy, R., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28671 · Cited by 10
Self-citationGyoten, T., Messroghli, D., Schenk, S., Rochor, K., Grimmig, O., Just, S., & Fritzsche, D. (2020) · Open Heart · doi:10.1136/openhrt-2019-001203 · Cited by 10
Alperi, A., del Val, D., Ferreira‐Neto, A. N., Bernier, M., Freitas‐Ferraz, A. B., Dagenais, F., & Rodés‐Cabau, J. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1781616 · Cited by 10
Reddy, Y. N. V., & Nishimura, R. A. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.2236 · Cited by 10
Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy
Biffi, M., Loforte, A., Folesani, G., Ziacchi, M., Attinà, D., Niro, F., Pasquale, F., & Pacini, D. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-265 · Cited by 10
Belluschi, I., Buzzatti, N., Castiglioni, A., Alfieri, O., & Bonis, M. D. (2020) · Mini-invasive Surgery · doi:10.20517/2574-1225.2020.48 · Cited by 10
Punnoose, L., & Lindenfeld, J. M. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.09.004 · Cited by 10
Self-citationInterventional echocardiography: Opportunities and challenges in an emerging field
Lee, J. C., Chen, T., & Gill, E. A. (2020) · Echocardiography · doi:10.1111/echo.14874 · Cited by 10
A review of the pivotal role of cardiac MRI in mitral valve regurgitation
Gajjar, K., Kashyap, K., Badlani, J. T., Williams, R. B., & Biederman, R. W. (2020) · Echocardiography · doi:10.1111/echo.14941 · Cited by 10
A scoping review to identify competencies for transcatheter cardiovascular procedures
Moran, H. R. M., Maurice-Ventouris, M. E. I., Alharbi, M., Harley, J. M., & Lachapelle, K. J. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.11.096 · Cited by 10
“Based on their usage inthe literature, thesewere then defined asnaming specific procedural steps, describing something using language such as “ skill, ” “ ability, ” “ knowledge, ” “ competency, ” or “ behaviour ” or otherwise implying that something is crucial to successfully perform the procedure…”
MethodValle, F. H., Mohammed, B., Wright, S. P., Bentley, R. F., Fam, N., & Mak, S. S. (2021) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2020.17 · Cited by 10
From secondary to tertiary mitral regurgitation: the paradigm shifts, but uncertainties remain
Landi, A., Faletra, F. F., Pavon, A. G., Pedrazzini, G. B., & Valgimigli, M. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab080 · Cited by 10
Transcatheter mitral valve replacement: an update
Aoun, J., Reardon, M. J., & Goel, S. S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000884 · Cited by 10
Sleep apnea and recurrent heart failure hospitalizations after coronary artery bypass grafting
Teo, Y. H., Tam, W., Koo, C. Y., Aung, A.-T., Sia, C., Wong, R. C.-C., Kong, W. K. F., Poh, K. K., Kofidis, T., Kojodjojo, P., et al. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9442 · Cited by 10
Doulamis, I. P., Tzani, A. I., Kampaktsis, P. Ν., Kaneko, T., & Tang, G. H. L. (2021) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2021.07.021 · Cited by 10
Coronary artery bypass grafting in low ejection fraction: state of the art
Robinson, N. B., Audisio, K., Bakaeen, F. G., & Gaudino, M. F. L. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000908 · Cited by 10
Martin, A., Bories, M.-C., Tence, N., Baudinaud, P., Pechmajou, L., Puscas, T., Marijon, É., Achouh, P., & Karam, N. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.713658 · Cited by 10
“Beyond being a surrogate of advanced cardiac disease, the presence of MR is considered as an aggravating factor (5, 6).”
BackgroundBiersmith, M. A., Orsinelli, D. A., Harfi, T. T., Lilly, S. M., & Boudoulas, K. D. (2022) · Echocardiography · doi:10.1111/echo.15470 · Cited by 10
Haberman, D., Dahan, S., Poles, L., Marmor, D. B., & Shuvy, M. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0276 · Cited by 10
Yokoyama, H., Ruf, T. F., Geyer, M., Tamm, A., Silva, J. G. D. R. E., Gößler, T. A. M., Zirbs, J., Schwidtal, B. L., Münzel, T. F., & von Bardeleben, R. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1029103 · Cited by 10
“Although the study indicated that M-TEER was implanted in 95% of the included patients and could keep the reduction of MR, leading to the significantly better clinical outcomes compared with the medical therapy (5), a sustained reverse remodeling of the left ventricle and the left atrium could not be achieved (34).”
ResultCalì, F., Pagnesi, M., Pezzola, E., Montisci, A., Metra, M., & Adamo, M. (2023) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30682 · Cited by 10
Kaddoura, R., Bhattarai, S., Abushanab, D., & Al-Hijji, M. A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.097 · Cited by 10
Gedela, M., Cangut, B., Safi, L. M., Krishnamoorthy, P. M., Pandis, D., El‐Eshmawi, A., & Tang, G. H. L. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.11.031 · Cited by 10
Kwon, D. H., Huang, S., Turkmani, M. M., Salam, D., Al-Dieri, D., Wang, T. K. M., Kapadia, S. R., Krishnaswamy, A., Gillinov, A. M., Svensson, L. G., et al. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.016006 · Cited by 10
Self-citationTrends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States⋆
Gupta, T., Khera, S., Kolte, D. S., Goel, K., Villablanca, P. A., Abbott, J. D., Fonarow, G. C., Rihal, C. S., Garcia, M. J., Bhatt, D. L., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.01.005 · Cited by 10
Ahmad, F., Petrie, M. C., McMurray, J. J. V., & Lang, N. N. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1463 · Cited by 10
Global regurgitant volume: approaching the critical mass in valvular-driven heart failure
Bartko, P. E., Arfsten, H., Heitzinger, G., Pávó, N., Spinka, G., Kastl, S., Prausmüller, S., Strunk, G., Mascherbauer, J., Hengstenberg, C., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez170 · Cited by 10
Kumar, A., Al-Khafaji, J. F., Shariff, M., Vaz, I., Adalja, D., & Doshi, R. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.02.019 · Cited by 10
Contemporary review of percutaneous therapy for tricuspid valve regurgitation
Nagaraja, V., Kapadia, S. R., Miyasaka, R., Harb, S. C., & Krishnaswamy, A. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1750370 · Cited by 10
“tant therapy for patients with severe mitral regurgitation who are at elevated surgical risk, and is the only FDA-approved device for percutaneous MR treatment [32,33].”
BackgroundSelf-citationVemulapalli, S., Prillinger, J. B., Thourani, V. H., & Yeh, R. W. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016140 · Cited by 10
Outcomes of MitraClip Placement in Patients With Liver Cirrhosis
Sawalha, K., Kadado, A. J., Gupta, K., Al‐Akchar, M., Battisha, A., Abozenah, M., Salerno, C., Gupta, M., Khan, A., & Islam, A. M. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.08.014 · Cited by 10
Echocardiographic evaluation of mitral valve regurgitation
Smer, A. M., Nanda, N. C., Akdogan, R. E., Elmarzouky, Z. M., & Dulal, S. (2020) · Mini-invasive Surgery · doi:10.20517/2574-1225.2020.36 · Cited by 10
Percutaneous Edge-to-Edge Mitral Valve Repair
Yeo, K. K., & Wong, N. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2020.0308 · Cited by 10
The unfinished saga of invasive procedures for secondary mitral regurgitation
Grinberg, D., Uhlrich, W., Thivolet, S., Buzzi, R., Rioufol, G., Obadia, J. F., & Pozzi, M. (2021) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2020-mv-15 · Cited by 10
Is it time to refresh the heart team? New paradigms for shared decision making
Yeoh, J., & MacCarthy, P. A. (2020) · Heart · doi:10.1136/heartjnl-2020-316588 · Cited by 10
Gröger, M., Scheffler, J. K., Schösser, F., Schneider, L. M., Rottbauer, W., Markovic, S., & Keßler, M. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13561 · Cited by 10
Characterizing mitral regurgitation in a contemporary population: prognostic implications
Delgado, V., Marsan, N. A., & Bax, J. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz432 · Cited by 10
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.